(Press-News.org) Young people who vape perform worse than non-vapers in tests designed to measure their capacity for exercise, according to a study presented at the European Respiratory Society (ERS) Congress in Vienna, Austria [1]. The research also showed that the performance of young vapers was similar to that of young smokers.
The study adds to growing evidence that long-term use of vaping is harmful and challenges the idea that vaping could be a healthier alternative to smoking.
The research was presented by Dr Azmy Faisal, senior lecturer in cardiorespiratory physiology in the department of sport and exercise sciences at Manchester Metropolitan University, UK. He said: “Previous research has shown that vaping is linked to lung inflammation and damage, and harmful changes to the blood vessels. Although, some research suggests that vaping could be used to cut back or quit smoking, we don’t yet know what longer-term vaping use does to our bodies.”
The study included 60 people in their 20s who all had normal lung function according to spirometry testing. Twenty were non-smokers and non-vapers, 20 had been vaping for at least two years and 20 had been smoking for at least two years.
Each person took part in an incremental exercise test on a static bike. This is the gold-standard for testing physical ability and how well a person copes with exercise, looking at their heart, lungs, and muscles’ responses at harder and harder levels until they reach their maximum. They were also given blood tests and an ultrasound scan to analyse how well their arteries were functioning.
On average, the group of young vapers had lower ‘peak exercise capacity’ (186 watts) than the group who did not vape or smoke (226 watts) but similar capacity to the group of smokers (182 watts). This is a measure of the maximum amount of physical exertion that a person can achieve. At peak exercise, vapers and smokers were also less able to consume oxygen on average (2.7 litres per minute and 2.6 litres per minute) compared to the non-smoking non-vaping groups (3 litres per minute).
Both vapers and smokers showed signs that their blood vessels were not working as well as the non-smoking and non-vaping group, according to the blood tests and ultrasound scans. The smokers and the vapers were more out of breath, experienced intense leg fatigue and had higher levels of lactate in their blood, a sign of muscle fatigue, even before they reached their maximum level of exercise.
Dr Faisal said: “In this study, we looked at a group of young people with no apparent signs of lung damage. Among the people who had been vaping or smoking for at least two years, we saw important differences in how well they coped with exercise. The smokers and the vapers had measurably excess breathing while using the exercise bikes. They found it harder to breath, their muscles became more fatigued, and they were less fit overall. In this regard, our research indicated that vaping is no better than smoking.”
Dr Filippos Filippidis is Chair of the ERS Tobacco Control Committee, a reader in public health at Imperial College London and was not involved in the research. He said: “Vapes are being sold cheaply and in a variety of flavours to appeal to young people. As a result, we’re seeing more and more young people take up the habit without knowing what the long-term consequences could be to their health.
“Although it’s always a challenge to know if the associations we find in these studies are causal or a result of some other systematic differences between groups, people who vape need to be aware that using these products could make them less fit and able to take part in exercise. Doctors and policymakers also need to know about the risks of vaping, and we should be doing all we can to support children and young people to avoid or quit vaping.”
END
Young vapers perform worse in exercise testing
2024-09-08
ELSE PRESS RELEASES FROM THIS DATE:
Medical clowns shorten hospital stays for children with pneumonia
2024-09-08
Spending time with a medical clown can shorten the length of hospital stay for children with pneumonia, according to research presented at the European Respiratory Society (ERS) Congress in Vienna, Austria [1]. They can also reduce the duration of intravenous antibiotic use.
The study was presented by Dr Karin Yaacoby-Bianu from Carmel Medical Center and the Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
She explains: “Medical clowns undergo specific training to work in hospitals. They have been shown to reduce ...
New report finds the changing nature of work provides new opportunities for workplace gender equality
2024-09-08
A new research report released today has identified an important shift in how employees choose to engage in the workforce, as they increasingly seek flexibility and opportunities to tailor work schedules and locations to their needs.
The ninth report in the Gender Equity Insights Series from the Bankwest Curtin Economics Centre (BCEC) and the Workplace Gender Equality Agency (WGEA) provides an in-depth analysis of the evolving nature of part-time work and implications of this change for the future of work in Australia.
Despite Australia having one of the highest shares of part-time employment across OECD countries, ...
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
2024-09-08
Insulin resistance is associated with 31 different diseases and, in women, is also linked to higher odds of an early death, a study of data on hundreds of thousands of people in the UK being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.
The conference will hear that there is compelling evidence of links between insulin resistance and conditions as diverse as Parkinson’s diease, gout and sciatica.
Insulin resistance, when the body’s cells don’t respond properly to insulin and can’t easily take up glucose from blood, is a key feature ...
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
2024-09-08
French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once a month, according to new research to be presented at this year’s annual meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
“Glucagon-like peptide-1 agonist (GLP-1) drugs have transformed type 2 diabetes care, but weekly injections can be burdensome for patients. A single shot a month could make it much easier for people living with diabetes or obesity to stick to their drug regimens, improving quality of life and reducing side effects and diabetes complications,” ...
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
2024-09-08
Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) suggests.
The study, from Rhian Hopkins and Ethan de Villiers, of the University of Exeter Medical School, University of Exeter, Exeter, UK, found evidence to suggest that a higher BMI is a cause of severe infections.
In contrast, there was no evidence that mild hyperglycamia contributes ...
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
2024-09-08
Long-term exposure to air pollution and a lack of access to green spaces increases the risk of hospitalisation for respiratory conditions, according to a study presented at the European Respiratory Society (ERS) Congress in Vienna, Austria [1].
Traffic-related air pollution is also strongly linked to the progression from asthma to asthma-COPD, according to a second study also presented at the ERS Congress [2].
Previous research has linked air pollution to an increase in respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), and ...
Better cardiovascular health in early pregnancy may offset high genetic risk
2024-09-07
Research Highlights:
Favorable cardiovascular health in early pregnancy, as measured by the American Heart Association’s Life’s Essential 8 (LE8) cardiovascular health score, was linked to lower risk of preeclampsia and gestational hypertension, otherwise known as hypertensive disorders of pregnancy.
The lower risk among study participants was consistent across different levels of genetic risk for these disorders.
Note: The studies featured in this news release are research abstracts. Abstracts presented at the American Heart Association’s scientific meetings are not peer-reviewed, ...
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
2024-09-07
(San Diego, Calif.--September 7, 2024, 8:30 a.m. PCT) — Research presented today suggests an artificial intelligence tool called DeepGEM may provide an advancement in genomic testing that offers an accurate, cost-effective, and timely method for gene mutation prediction from histopathology slides.
The research was presented today at the IASLC 2024 World Conference on Lung Cancer by Professor Wenhua Liang, from the China State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, China.
Accurate ...
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
2024-09-07
(San Diego, Calif.--September 7, 2024, 8:30 a.m. PDT)--The antibody–drug conjugate
ifinatamab deruxtecan (I-DXd) showed clinically meaningful responses in pretreated patients with extensive-stage small cell lung cancer (ES-SCLC), according to an interim analysis of the Phase 2 IDeate-Lung01 study. The data was presented today at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer.
Patients with ES-SCLC face poor outcomes and have limited treatment options. B7 homolog 3 (B7-H3 [CD276]) is part of the B7 family, which includes immune checkpoint proteins such as PD-L1. B7-H3 is highly expressed in many solid tumors ...
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
2024-09-07
[San Diego, Calif --September 7, 2024, 8:30 a.m. PCT)– Despite significant improvements in the perception of biomarker testing compared to a 2018 survey, substantial barriers to implementation persist globally, according to results of the 2024 IASLC Global Survey on Biomarker Testing released today at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2024.
The 2018 survey revealed the adoption of biomarker testing was low due to cost, lack of quality and standards, ...